TVRD · Tvardi Therapeutics, Inc. · Documents
$1.02
+0.03 (+2.82%)
At close · Oct 21
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As a result, the Company has concluded that management's plans do not alleviate substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$13.87M
Shares
13.34M
Volume · Oct 21
136.8K
Avg daily vol (3M)
242.64K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2021-06-07 | 2021-06-03 | |
| 8-K | — | 2021-05-10 | — | |
| 10-Q | — | 2021-05-10 | 2021-03-31 | |
| 8-K | — | 2021-04-29 | — | |
| DEF 14A | — | 2021-04-23 | 2021-06-03 | |
| 8-K | — | 2021-03-30 | — | |
| 8-K | — | 2021-03-08 | — | |
| 10-K | — | 2021-02-25 | 2020-12-31 | |
| 8-K | — | 2021-02-25 | — | |
| 8-K | — | 2020-12-28 | — | |
| 10-Q | — | 2020-11-09 | 2020-09-30 | |
| 8-K | — | 2020-11-09 | — | |
| 8-K | — | 2020-10-20 | 2020-10-15 | |
| 8-K | — | 2020-10-01 | — | |
| 8-K/A | — | 2020-08-11 | 2020-06-04 | |
| 10-Q | — | 2020-08-10 | 2020-06-30 | |
| 8-K | — | 2020-08-10 | — | |
| 8-K | — | 2020-06-30 | 2020-06-26 | |
| 8-K | — | 2020-06-17 | — | |
| 8-K | — | 2020-06-05 | 2020-06-04 | |
| 10-Q | — | 2020-05-11 | 2020-03-31 | |
| 8-K | — | 2020-05-11 | — | |
| DEF 14A | — | 2020-04-22 | 2020-06-04 | |
| 8-K | — | 2020-04-21 | — | |
| 8-K | — | 2020-03-25 | — | |
| 8-K | — | 2020-02-27 | — | |
| 10-K | — | 2020-02-27 | 2019-12-31 | |
| 8-K | — | 2020-01-14 | — |
Showing 101–128 of 128 filings